Episode 2: From Innovation to Impact: The RNA Interference Era Begins Podcast By  cover art

Episode 2: From Innovation to Impact: The RNA Interference Era Begins

Episode 2: From Innovation to Impact: The RNA Interference Era Begins

Listen for free

View show details

About this listen

Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.

No reviews yet